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MaIn a 37-year-old cardiac arrest survivor with autosomal dominant Carvajal syndrome and arrhythmogenic cardiomyopa-
thy, a desmoplakin mutation was identified. Cascade screening identified 2 affected family members and 2 healthy
children carrying the mutation. Strategies for primary and secondary risk prevention emphasize the role of genetic
testing in rare cardiomyopathies. (Level of Difficulty: Advanced.) (J Am Coll Cardiol Case Rep 2020;2:925–9)
© 2020 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).HISTORY OF PRESENTATION
A 37-year-old woman had a witnessed cardiac arrest
while she was jogging, and she was resuscitated by
DC shock following detection of ventricular fibrilla-
tion. She had been a competitive athlete until the age
of 30 years and had never reported symptoms or
events. On admission she was hemodynamically sta-
ble. The electrocardiogram (ECG) showed sinus
bradycardia, low QRS voltages, and nonspecific
repolarization abnormalities, especially in leads V4 toN 2666-0849
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years earlier in the course of a sports medicine eval-
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Italian laws) (Figures 1A and 1B). No major rhythm
disturbances were recorded. The echocardiogram
showed mild biventricular hypokinesia with reduced
left ventricular (LV) systolic dysfunction (ejection
fraction 46%) and limited areas of bulging of the free
right ventricular (RV) wall, which was richly trabe-
culated (Figure 1E). Laboratory tests revealed a light
increase in serum creatinine and troponin I levels.https://doi.org/10.1016/j.jaccas.2020.03.033
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LEARNING OBJECTIVES
 To diagnose rare forms of arrhythmogenic
cardiomyopathies associated with extrac-
ardiac manifestations and increased risk of
SCD.
 To understand the complexities of genetic
testing interpretation in the era of next-
generation sequencing.





LV = left ventricular
RV = right ventricular
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926The only notable finding on clinical exami-
nation was marked palmar hyperkeratosis,
attributed to her job as a gardener (Figure 1C).
PAST MEDICAL HISTORY
The patient was the mother of 2-year-old
nonidentical male triplets. She had a positive
family history of sudden cardiac death. Her To perform cascade genetic screening in
family members, to identify early manifes-
tation and implement tailored preventive
strategies for sudden cardiac death
possibly ranging from device implantation to
lifestyle interventions, depending on the
patient.brother, with a history of scalp dermatitis and woolly
hair from infancy, died suddenly several years earlier
at the age of 28 years. He was a competitive athlete
with unexplained recurrent syncope, low-voltage
complexes on the ECG, and polymorphic ventricular
ectopies on 24-h Holter ECG. Cardiac investigations
had been inconclusive at a time when arrhythmo-
genic cardiomyopathy (AC) was still little known. The
patient’s maternal grandmother’s sister, reportedly
affected by dilated cardiomyopathy, died suddenly at
the age of 40 years. The proband’s mother and
maternal uncle showed mild RV abnormalities and
scalp dermatitis.
DIFFERENTIAL DIAGNOSIS
Coronary angiography excluded epicardial stenoses.
Cardiac magnetic resonance revealed patchy areas of
edema within the LV lateral wall in T2-weighted im-
ages and mild RV dilation with sparse areas of non-
compaction and saccular dilatations; the left ventricle
showed hypokinesia of the distal interventricular
septum with an LV ejection fraction of 52%, apical
noncompaction, and diffuse subepicardial late gado-
linium enhancement (Figures 1D and 1F). The combi-
nation of clinical and instrumental findings raised the
suspicion of AC on the basis of her family history.
INVESTIGATIONS
Genetic testing was performed by whole exome
sequencing, allowing the identification of 2 rare var-
iants of heterozygosity co-segregating with the car-
diocutaneous phenotype in the mother and uncle
(Figure 2): 1) c.878A>T, p.(Glu293Val) in the desmo-
somal protein gene desmoplakin (DSP); and 2)
c.626A>C, p.(Tyr209Ser) in SCO2, a cytochrome c
oxidase (COX) assembly gene. Of these, the DSP
variant appeared fully compatible with the initial
clinical suspicion and the phenotypic features of the
proband and her family. Because the cardiomyopathy
related to SCO2 gene variants is usually recessive and
associated with encephalopathy and it is fatal in
children, we excluded the causative role of this gene
in our family. On the basis of these results, adiagnosis of autosomal dominant Carvajal syndrome
was made.
MANAGEMENT
The patient was discharged following implantation of
a single-lead cardioverter-defibrillator. Two months
after discharge, she was hospitalized twice for
recurrent episodes of incessant monomorphic ven-
tricular tachycardia unresponsive to medical therapy.
Electrophysiological LV mapping was compatible
with a large area of scar in the midbasal anterolateral
wall that was successfully treated by epicardial
transcatheter ablation.
Following multidisciplinary consultation,
including the cardiomyopathy team, a psychiatrist,
and a clinical geneticist, the proband’s sons under-
went cascade genetic screening at the age of 10 years.
Two of 3 were found to carry the DSP variant, in the
absence of cardiac abnormalities or arrhythmias. Af-
ter proper counseling with the help of an experienced
psychiatrist, both were gradually diverted from
competitive sports and encouraged to pursue alter-
native activities. This strategy was chosen despite the
lack of clinical manifestations because of the impact
of sports in their family, and it was based on recent
published reports on AC that showed an association
of earlier and more severe phenotypes with vigorous
physical activity in mutation carriers.
The proband’s mother and uncle had a definite but
mild AC phenotype; both carried the DSP variant.
Following thorough noninvasive investigation, no
arrhythmic propensity could be demonstrated except
for a limited number of ventricular ectopies on 24-h
Holter monitoring. Both were in their late 60s and
judged to be at low arrhythmic risk. They were started
on nadolol and entered routine clinical follow-up.
FIGURE 1 Clinical, ECG, and Instrumental Features
(A) The 12-lead electrocardiogram on admission was comparable to (B) one performed 5 years earlier. (C) Palmar keratoderma. (D and F) Cardiac magnetic resonance
and (E) echocardiographic images of right ventricular wall aneurysms (red and white arrows) and hypertrabeculation; diffuse subepicardial late gadolinium
enhancement is evident (blue arrows). IVS ¼ interventricular septum; LA ¼ left atrium; LV ¼ left ventricle; RA ¼ right atrium; RV ¼ right ventricle.
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927FOLLOW-UP
The proband remained asymptomatic and free of
arrhythmic recurrences in the ensuing 8 years while
taking nadolol, 80 mg once daily, and avoiding sports
and strenuous exercise in general. No further
arrhythmic events were recorded by the implantable
cardioverter-defibrillator.
DISCUSSION
Desmosomes are highly specialized cell adhesion
junctions, comprising several different proteins such
as desmoplakin and plakoglobin, that confer resis-
tance to mechanical stress and preserve cellular
integrity in cardiac tissue and epidermis. Carvajal
disease is a rare autosomal recessive cardiocutaneous
syndrome, characterized by biventricular or LVdilated cardiomyopathy, palmoplantar keratoderma,
and woolly hair, that is associated with DSP gene
mutations (1–4). Desmoplakin plays a critical role in
the desmosomal junction by anchoring the cytoskel-
eton to the plasma membrane. Altered protein-
protein interactions at the intercalated disk level are
responsible for contractile and electrical dysfunction
in Carvajal syndrome (2). Very few cases of dominant
inheritance have been described (5,6), and little is
known regarding desmosomal gene–related car-
diocutaneous syndromes.
Even though the diagnosis of arrhythmogenic
cardiomyopathy is multiparametric and mostly
clinical, genetic testing plays a leading role in man-
agement, both for differential diagnosis with
cardiocutaneous or Costello syndromes and for
proper screening in pre-symptomatic relatives. Next-
generation sequencing has revolutionized the field of
FIGURE 2 Genetic Findings
A dominant pattern of inheritance was evident in the family pedigree after genetic cascade screening. DSP ¼ desmoplakin gene.
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covery of novel disease-causing genes (7,8). In the
present case, a whole exome sequencing approach
allowed the identification of the DSP variant. A posi-
tive genetic test result has important implications for
risk management in AC-affected families. Here, we
were able to identify 2 affected family members with
a mild AC phenotype. In both these family members,
a diagnosis would likely have been overlooked on the
basis of clinical criteria alone. This finding allowed
tailored arrhythmic risk assessment and imple-
mentation of surveillance strategies. Importantly, in 2
of the proband’s triplets, gene testing allowed early
implementation of lifestyle preventive measures, by
restricting participation in the competitive sports in
which both sons were engaged. Although the ultimate
efficacy of such a strategy will be observed only in the
very long term, the rationale is sound and is based on
the established association between sports and
arrhythmic risk in desmosomial diseases (9,10).Of note, similar measures possibly could have pre-
vented major arrhythmic events in the proband and
in her brother, both with long records of competitive
sports participation.
CONCLUSIONS
We report an autosomal dominant form of AC in the
context of Carvajal syndrome caused by a novel DSP
gene variant. This case exemplifies the different
levels of prophylactic interventions required in the
management of genetic arrhythmic diseases,
including lifestyle modifications in healthy mutation
carriers.
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